Browse
You are looking at 1 - 10 of 20 items for :
- Transplantation x
- Clinical Care x
- Refine by Content Type: News x
ASN also renews its call for a systemwide set of improvements for the organ transplantation program.
In a letter to HRSA, ASN emphasized the need for separating the technology portion of the OPTN contract as a stand-alone contract, requiring OPTN contractors to have complete and accurate data, and the enforcement of separate governance boards.
Pig kidneys were successfully implanted into a human and functioned normally. Surgeons hope to start clinical trials with kidney patients later this year.
A team of surgeons at NYU Langone Health in New York have transplanted a pig kidney into a human patient without triggering immediate rejection by the recipient’s immune system.
Priority #2: TRANSFORM TRANSPLANT and increase access to donor kidneys. If patients understood the benefits of transplantation and the process involved, more would likely accept the opportunity and pursue transplant listing.
ASN applauds the U.S. Food and Drug Administration for amending the emergency use authorizations for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, including kidney transplant recipients.
Investigators discovered that kidney failure symptoms tended to increase or remain unchanged between transplant evaluation and transplantation; however, three months after transplantation, 9 of 11 symptoms lessened.
Kidney transplantation saves lives. For many people with kidney failure, transplant offers longer survival, greater quality of life, and lower associated costs compared to dialysis.
The Centers for Medicare & Medicaid Services (CMS) has asked ASN to share with its members that the ESRD Quality Reporting System (EQRS) has been suspended due to data submitting issues.
Users are asked not to submit additional data at this time. CMS writes “We are committed to ensuring the accuracy and reliability of our data, and are working to rapidly resolve these issues.”
This week, the Baylor College of Medicine became the first academic center and care provider to publicly announce its support for the changes included in Medicare’s proposed rule on Organ Procurement Organizations (OPOs) Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organizations – joining the American Society of Nephrology (ASN) in its support of the proposed rule. ASN expressed its support in a separate comment letter and made recommendations for improvement. (ASN’s comments and recommendations will be covered in Kidney News’ March edition.)
